Aquestive Therapeutics (AQST) vs Canopy Growth (CGC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Aquestive Therapeutics (AQST) has outperformed Canopy Growth (CGC) over the past year, losing 28.6% versus a loss of 49.9%. Over five years, AQST leads with a +23.5% price change compared with -99.4% for CGC. Aquestive Therapeutics is the larger company by market cap ($599.9 million vs $371.6 million), about 1.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AQST | CGC |
|---|---|---|
| Share price | $4.78 | $0.8271 |
| Market cap | $599.95M | $371.62M |
| 1-day change | +0.42% | -2.33% |
| YTD return | -26.01% | -27.45% |
| 1-year return | -28.55% | -49.87% |
| 5-year return | +23.51% | -99.38% |
| EPS (TTM) | $-0.66 | $-0.44 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.55 | $2.38 |
| 52-week low | $2.93 | $0.81 |
| Distance from 52-week high | -36.69% | -65.25% |
| Analyst consensus | none | none |
| Avg. price target upside | +95.19% | +45.09% |
| Average volume | 2.66M | 2.80M |
| Shares outstanding | 125.51M | 423.04M |
| Employees | 147 | 1,128 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AQST has outperformed CGC by 21.3 percentage points over the past year.
About Aquestive Therapeutics
AQST stock →Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally.
Health Care · Biotechnology: Pharmaceutical Preparations · 147 employees
About Canopy Growth
CGC stock →Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel.
Health Care · Medicinal Chemicals and Botanical Products · 1,128 employees
AQST vs CGC FAQ
Which is bigger, Aquestive Therapeutics or Canopy Growth?
Aquestive Therapeutics (AQST) is larger, with a market capitalization of $599.95M compared with $371.62M for Canopy Growth (CGC).
Which stock has performed better over the past year, AQST or CGC?
AQST returned -28.55% over the past 12 months, compared with -49.87% for CGC (price return, excluding dividends). Past performance does not predict future results.
Are Aquestive Therapeutics and Canopy Growth in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Aquestive Therapeutics and Medicinal Chemicals and Botanical Products for Canopy Growth.